Recent studies indicated that miR-214-3p inhibited proliferation or tumor progression by targeting FGFR1 in the differentiation process of osteogenic mesenchymal stem cells and colorectal cancer, which was consistent with our research47,48. The gene discussed is FGFR1; the disease is colorectal cancer.